175 related articles for article (PubMed ID: 19450226)
1. Use of gastrointestinal proton pump inhibitors to regulate osteoclast-mediated resorption of calcium phosphate cements in vivo.
Sheraly AR; Lickorish D; Sarraf F; Davies JE
Curr Drug Deliv; 2009 Apr; 6(2):192-8. PubMed ID: 19450226
[TBL] [Abstract][Full Text] [Related]
2. Osteoclastic differentiation and resorption is modulated by bioactive metal ions Co2+, Cu2+ and Cr3+ incorporated into calcium phosphate bone cements.
Bernhardt A; Schamel M; Gbureck U; Gelinsky M
PLoS One; 2017; 12(8):e0182109. PubMed ID: 28763481
[TBL] [Abstract][Full Text] [Related]
3. Proton pump inhibitors control osteoclastic resorption of calcium phosphate implants and stimulate increased local reparative bone growth.
Rzeszutek K; Sarraf F; Davies JE
J Craniofac Surg; 2003 May; 14(3):301-7. PubMed ID: 12826800
[TBL] [Abstract][Full Text] [Related]
4. Pantoprazole decreases cell viability and function of human osteoclasts in vitro.
Prause M; Seeliger C; Unger M; Rosado Balmayor E; van Griensven M; Haug AT
Mediators Inflamm; 2015; 2015():413097. PubMed ID: 25873758
[TBL] [Abstract][Full Text] [Related]
5. Simvastatin-doped pre-mixed calcium phosphate cement inhibits osteoclast differentiation and resorption.
Montazerolghaem M; Rasmusson A; Melhus H; Engqvist H; Karlsson Ott M
J Mater Sci Mater Med; 2016 May; 27(5):83. PubMed ID: 26968758
[TBL] [Abstract][Full Text] [Related]
6. Strontium substitution in apatitic CaP cements effectively attenuates osteoclastic resorption but does not inhibit osteoclastogenesis.
Schumacher M; Wagner AS; Kokesch-Himmelreich J; Bernhardt A; Rohnke M; Wenisch S; Gelinsky M
Acta Biomater; 2016 Jun; 37():184-94. PubMed ID: 27084107
[TBL] [Abstract][Full Text] [Related]
7. Differentiation and activity of human preosteoclasts on chitosan enriched calcium phosphate cement.
Rochet N; Balaguer T; Boukhechba F; Laugier JP; Quincey D; Goncalves S; Carle GF
Biomaterials; 2009 Sep; 30(26):4260-7. PubMed ID: 19481081
[TBL] [Abstract][Full Text] [Related]
8. Resorption of monetite calcium phosphate cement by mouse bone marrow derived osteoclasts.
Montazerolghaem M; Karlsson Ott M; Engqvist H; Melhus H; Rasmusson AJ
Mater Sci Eng C Mater Biol Appl; 2015; 52():212-8. PubMed ID: 25953560
[TBL] [Abstract][Full Text] [Related]
9. Proton pump (H+/K+-ATPase) inhibitors weaken the protective effect of alendronate on bone mechanical properties in estrogen-deficient rats.
Pytlik M; Cegieła U; Folwarczna J; Nowińska B
Pharmacol Rep; 2012; 64(3):625-34. PubMed ID: 22814016
[TBL] [Abstract][Full Text] [Related]
10. Effect of omeprazole, an inhibitor of H+,K(+)-ATPase, on bone resorption in humans.
Mizunashi K; Furukawa Y; Katano K; Abe K
Calcif Tissue Int; 1993 Jul; 53(1):21-5. PubMed ID: 8102318
[TBL] [Abstract][Full Text] [Related]
11. Formation of osteoclasts on calcium phosphate bone cements and polystyrene depends on monocyte isolation conditions.
Bernhardt A; Schumacher M; Gelinsky M
Tissue Eng Part C Methods; 2015 Feb; 21(2):160-70. PubMed ID: 24919531
[TBL] [Abstract][Full Text] [Related]
12. Acidification of the osteoclastic resorption compartment provides insight into the coupling of bone formation to bone resorption.
Karsdal MA; Henriksen K; Sørensen MG; Gram J; Schaller S; Dziegiel MH; Heegaard AM; Christophersen P; Martin TJ; Christiansen C; Bollerslev J
Am J Pathol; 2005 Feb; 166(2):467-76. PubMed ID: 15681830
[TBL] [Abstract][Full Text] [Related]
13. Lycopene I--effect on osteoclasts: lycopene inhibits basal and parathyroid hormone-stimulated osteoclast formation and mineral resorption mediated by reactive oxygen species in rat bone marrow cultures.
Rao LG; Krishnadev N; Banasikowska K; Rao AV
J Med Food; 2003; 6(2):69-78. PubMed ID: 12935316
[TBL] [Abstract][Full Text] [Related]
14. Total coumarins from fruits of Cnidium monnieri inhibit formation and differentiation of multinucleated osteoclasts of rats.
Qin LP; Zhang QY; Tian YP; Zheng HC; Haung M; Huang BK
Acta Pharmacol Sin; 2003 Feb; 24(2):181-6. PubMed ID: 12546728
[TBL] [Abstract][Full Text] [Related]
15. Quercetin triggers apoptosis of lipopolysaccharide (LPS)-induced osteoclasts and inhibits bone resorption in RAW264.7 cells.
Guo C; Hou GQ; Li XD; Xia X; Liu DX; Huang DY; Du SX
Cell Physiol Biochem; 2012; 30(1):123-36. PubMed ID: 22759961
[TBL] [Abstract][Full Text] [Related]
16. The resorption of nanocrystalline calcium phosphates by osteoclast-like cells.
Detsch R; Hagmeyer D; Neumann M; Schaefer S; Vortkamp A; Wuelling M; Ziegler G; Epple M
Acta Biomater; 2010 Aug; 6(8):3223-33. PubMed ID: 20206720
[TBL] [Abstract][Full Text] [Related]
17. Incorporation of RANKL promotes osteoclast formation and osteoclast activity on β-TCP ceramics.
Choy J; Albers CE; Siebenrock KA; Dolder S; Hofstetter W; Klenke FM
Bone; 2014 Dec; 69():80-8. PubMed ID: 25245204
[TBL] [Abstract][Full Text] [Related]
18. Similar healthy osteoclast and osteoblast activity on nanocrystalline hydroxyapatite and nanoparticles of tri-calcium phosphate compared to natural bone.
MacMillan AK; Lamberti FV; Moulton JN; Geilich BM; Webster TJ
Int J Nanomedicine; 2014; 9():5627-37. PubMed ID: 25506216
[TBL] [Abstract][Full Text] [Related]
19. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
Michael H; Härkönen PL; Väänänen HK; Hentunen TA
J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
[TBL] [Abstract][Full Text] [Related]
20. Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption.
Vitté C; Fleisch H; Guenther HL
Endocrinology; 1996 Jun; 137(6):2324-33. PubMed ID: 8641182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
